Claims
- 1. A method for amelioration of traction retinal detachment comprising contacting the retinal pigmented epithelial cells of a subject in need thereof with a therapeutic amount of a retinoic acid receptor agonist.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation of U.S. Ser. No. 09/536,221, filed Mar. 27, 2000 now U.S. Pat. No. 6,372,753; which is a continuation of U.S. Ser. No. 08/875,665, filed Jan. 23, 1998 (U.S. Pat. No. 6,075,032, issued Jun. 13, 2000); which is a PCT National Phase Application of PCT/US96/01505, filed Jan. 31, 1996, which published in English as WO 96/23498 on Aug. 8, 1996; and continuation-in-part of U.S. Ser. No. 08/383,741, filed Feb. 1, 1995 (U.S. Pat. No. 5,824,685, issued Oct. 20, 1998).
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5234926 |
Chandraratna |
Aug 1993 |
A |
Non-Patent Literature Citations (1)
Entry |
Fekrat, S., et al. “The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy.” Opthalmology, Mar. 1995, pp. 412-418, XP000942676. |
Continuations (2)
|
Number |
Date |
Country |
Parent |
09/536221 |
Mar 2000 |
US |
Child |
09/954686 |
|
US |
Parent |
08/875665 |
|
US |
Child |
09/536221 |
|
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
08/383741 |
Feb 1995 |
US |
Child |
08/875665 |
|
US |